ANP's going much higher, maybe not on the daily but look at all the biotechs with drugs in Phase I studies at $100M and posters banging on about the significance of Orphan Drug Designation etc etc ANP has 3 x Phase II Orphan Drug Designation on 2 of those from both FDA & EMA and cash out to end of next year...… less than $20M MC ?
